Enanta Pharmaceuticals Inc (ENTA.OQ)

ENTA.OQ on NASDAQ Stock Exchange Global Select Market

2 Jun 2015
Change (% chg)

$-0.46 (-1.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENTA.OQ


Enanta Pharmaceuticals, Inc. is a research and development-focused biotechnology company that uses its robust chemistry-driven approach and drug discovery capabilities to create small molecule drugs for viral infections and liver diseases. The Company is discovering, and in some cases developing, inhibitors designed for use... (more)


Beta: --
Market Cap(Mil.): $767.12
Shares Outstanding(Mil.): 18.69
Dividend: --
Yield (%): --


  ENTA.OQ Industry Sector
P/E (TTM): 6.83 320.15 38.67
EPS (TTM): 6.01 -- --
ROI: 70.16 -5.51 15.73
ROE: 71.04 -6.49 16.79
Search Stocks

BRIEF-Private Equity Holding's portfolio Company Enanta gets U.S. FDA Approval for AbbVie's VIEKIRA PAK

* Private Equity Holding: portfolio company Enanta announces U.S. FDA approval for AbbVie's VIEKIRA PAK

22 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Jefferson Research
Provider: Ford Investor Services, Inc.
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks